Study reinforces HPV vaccine is saving lives

Researchers at QIMR Berghofer Medical Research Institute and the University of Queensland have found young women who received the HPV vaccine are far less likely to develop high-risk abnormalities that can lead to cervical cancer.

They used Queensland Health datasets to show these women had a 46 % lower risk of developing high-grade changes in the cervix, compared with women who had not been vaccinated.

Cervical cancer is one of the most common causes of gynaecological cancer, killing more than 200 Australian women every year.

Continue reading “Study reinforces HPV vaccine is saving lives”

Vaccine decreases pre-cancerous symptoms in Aussie women by 93%

Researchers have reported an incredible 93% drop in genital wart diagnoses (symptoms of the human papillomavirus) in young women who have received the HPV, or cervical cancer, vaccine.

The vaccine, co-created by Professor Ian Frazer AC (whose research was supported by an early ACRF seed-funding grant), became available for Australian girls in 2007.

The study, which was conducted by researchers at the University of NSW and the University of Melbourne together with both the Sydney and Melbourne Centres of Sexual Health, looked at the medical data of 85,770 patients during pre-vaccination period (2004-2007) compared to the vaccination period (2007-2011). Continue reading “Vaccine decreases pre-cancerous symptoms in Aussie women by 93%”

Research news: spring 2012 edition

Current cancer researchIn the Spring edition of the Research Review:

  • Researchers have found a target for treating up to 50% of childhood cancer cases.
  • An ambitious Melanoma Genome Project has launched, with the aim of identifying all common mutations within melanoma cancers.
  • The Prime Minister, Julia Gillard has officially opened the world-class Kinghorn Cancer Centre in Sydney.